Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 849
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
67123
If I look at the whacky one day chart on ihub
(1)
rumpus008
11/06/2020 1:23:06 PM
67121
Please don't post a link without explanation.
(2)
Drano
11/06/2020 10:40:05 AM
67120
In other words, this virus is going to be around
(1)
incubus
11/06/2020 10:18:16 AM
67119
https://www.biorxiv.org/content/10.1101/2020.11.0
(1)
thumbgreen
11/06/2020 8:57:51 AM
67118
IMO....the only issue holding this stock back is
(2)
Commando911
11/05/2020 9:36:11 PM
67117
Right on, our country really need more skilled
Commando911
11/05/2020 9:34:29 PM
67116
Just do it then. Don't know your age or income
(8)
scgmck1
11/05/2020 8:30:37 PM
67115
I want to add shares tomorrow. Might thought is
(2)
angeli
11/05/2020 4:57:51 PM
67113
125,000 of that volume today was me with multiple
(9)
DrTim
11/05/2020 2:24:26 PM
67109
Sorry guys I thought it was an interesting
(1)
zdubble17
11/05/2020 10:24:59 AM
67107
It's best not to reply to troll posts that are
Drano
11/05/2020 10:00:19 AM
67097
No politics. Period. Interesting that
(3)
Drano
11/04/2020 3:22:38 PM
67095
I have to keep reminding myself....the trial will
(2)
Chemdeps
11/04/2020 1:00:27 PM
67092
Flu season is upon us. Wouldnt it be
(2)
Ultimate
11/04/2020 10:58:00 AM
67086
Thank you. A good read and very well said. Gilead
(6)
Ultimate
11/03/2020 10:42:39 AM
67080
I am in total agreement with you across the
(16)
petemantx
11/03/2020 9:08:31 AM
67079
Brilacidin has been very effective in killing
(2)
angeli
11/03/2020 9:05:48 AM
67077
Incredible post and rationale Mo! I hope IF a
(2)
YoggingMarathon
11/03/2020 1:29:30 AM
67076
The Preprint highlights the dire need to have an
(22)
Mo
11/03/2020 1:13:03 AM
67075
Well said Mo......the next few months should be
(6)
falcon74
11/03/2020 12:24:26 AM
67074
Great news today on the green light given from
(19)
Mo
11/03/2020 12:09:20 AM
67073
20201102|IPIX|2215465|0|3677209|O
(9)
4kids
11/02/2020 6:04:32 PM
67072
A poster on another board listed lyme disease as
thttlpckg
11/02/2020 5:59:40 PM
67069
Looks like people are understanding that there is
(7)
Drano
11/02/2020 2:59:27 PM
67068
https://apnews.com/press-release/globe-newswire/b
(5)
Ultimate
11/02/2020 1:30:27 PM
67067
Sounds like that 65 million was slated to come
Fit007
11/02/2020 12:24:25 PM
67066
Remember how BARDA abruptly canceled their grant
(1)
Drano
11/02/2020 11:22:42 AM
67065
Researchers are going day and night to try to
(2)
Drano
11/02/2020 11:02:31 AM
67064
With thousands dying daily holidays shouldnt
(3)
stocker11
11/02/2020 10:42:08 AM
67063
They changed the wording of the trial from
(5)
thttlpckg
11/02/2020 10:17:02 AM
67062
Drano.....With the holidays coming up, I am
falcon74
11/02/2020 10:16:51 AM
67061
The ol' one-two punch. This should be a very
(15)
Drano
11/02/2020 9:53:06 AM
67060
Got the GO AHEAD to get that much needed
(4)
NotRichYet2
11/02/2020 9:39:39 AM
67059
Q4 2020......Awesome! Quick trial with interim
(3)
zdubble17
11/02/2020 9:37:40 AM
67058
Innovation Pharmaceuticals Receives Pre-IND
(14)
someconcerns
11/02/2020 9:29:00 AM
67057
Thanks Mo. Good stuff.
(1)
Pipilongstocking
11/02/2020 12:25:23 AM
67054
Its very pleasing to read the results, the
(7)
pizza
11/01/2020 7:24:30 PM
67050
This company has a history of surprising us with
(10)
Drano
11/01/2020 2:00:11 PM
67049
I agree and I suspect that Leo does too. This is
(7)
Ultimate
11/01/2020 10:53:40 AM
67048
I expect that Brilacidin will also be a vaccine
(2)
stocker11
11/01/2020 10:30:42 AM
67047
It seems like Gilead isnt the only partner
(6)
Ultimate
11/01/2020 10:16:07 AM
67046
When my wife and I tested positive we were told
petemantx
11/01/2020 10:10:13 AM
67045
There are studies that have shown that the most
(1)
Drano
11/01/2020 10:02:51 AM
67044
OT question in regard to COVID : Though there are
NotRichYet2
11/01/2020 9:50:51 AM
67043
If there is a partnership IPIX should get 95% of
(4)
stocker11
11/01/2020 9:36:14 AM
67041
Great summary Mo. The medical world will be
(1)
Jimvette
11/01/2020 8:49:30 AM
67040
The IPIX Preprint of Brilacidin for COVID-19
(18)
Mo
11/01/2020 2:33:54 AM
67038
After reading your great post I believe others
(4)
petemantx
10/31/2020 10:07:11 PM
67037
Just as a mental exercise, what if the new
(7)
4kids
10/31/2020 9:04:26 PM
67036
Just as a mental exercise, what if the new
(7)
petemantx
10/31/2020 6:47:52 PM
Newer
Older
Recent Articles
Shenzhen's Transformative Influence on Global Branding and Quality
Jiangsu's Transformation: Merging Rich History with Innovation
Hexagon Purus ASA Reports Record Q3 Growth and Future Plans
CTP Delivers State-of-the-Art Logistics Facility to Tesco
Galderma's Nemolizumab Shows Promising Results for Itch Relief
Explore Tokyo Psychodemic: An Immersive Gaming Experience
Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
CoinEx Charity's Starlink Initiative Transforms Connectivity
Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
Akeso's Cadonilimab and Ivonescimab Added to National Drug List
TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
Bridging Cultures: China and Europe's River Dialogues
The Surge in Population Health Management: A $663.75 Billion Future
Prime Mining Releases New Technical Report on Los Reyes Project
Investigation Announced for Symbotic Inc. Shareholders
Monument Mining Limited Reports Positive Q1 FY 2025 Results
Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
Innovative Approaches to Combat the Fall Armyworm Crisis
Exro Technologies Faces Potential Class Action Suit
BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
BioArctic Partners with Eisai for Leqembi Launch in Asia
Rakovina Therapeutics Unveils New Financial Strategy for Growth
Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
AIP Realty Trust Reports Q3 Financial Progress and Future Growth
Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
Celsius Holdings Faces Legal Challenges—What Investors Should Know
Lomiko Metals Secures Funding for La Loutre Graphite Project
U.S. Gold Corp. Launches Significant $10.2 Million Offering
Key Insights into the Growth of the Medical Nonwoven Market
Exploring the Growth of the Portable Power Station Market
Investors Alert: Class Action Update on Edwards Lifesciences
Casio Unveils Iconic DW-5000R, A Nod to G-SHOCK Heritage
Casio Unveils New DW-5000R, Reviving G-SHOCK's Legacy
American Lithium's Annual Meeting Highlights and Future Plans
Rentokil Initial PLC Faces Class Action Claims - Key Insights
Significant Jury Victory for Guardant Health Against Natera
Robbins LLP Highlights Class Action Opportunities for AILE Investors
Legal Update: Dentsply Sirona Inc. Class Action Notification
Exploring Growth within the Animal Feed Additives Industry
Women’s Watch Market Set for Significant Growth by 2031
Eisai and Biogen Launch LEQEMBI for Alzheimer's in New Markets
Patterson Companies to Host Second Quarter Conference Call
Metafy Partners with Lucky Kat to Enhance Kumo Brand Growth
Projection of US$ 3.6 Billion in Aircraft Cabin Composites
Explore the Galaxy with $DUKE: The New Meme Coin Sensation
Understanding the Recent Distribution Notification from SABA Fund